AEVIS N

AEVS SIX Swiss Exchange Healthcare & Biotech Switzerland
12.65 Fr.
1.20 %

Swiss company specializing in the management of medical and hotel facilities, combining Swiss healthcare and hospitality services.

Performance & Momentum

6 Months 0.38 %
1 Year 3.00 %
3 Years 28.09 %
5 Years 9.42 %

Strategic Analysis

AEVIS N operates in a hybrid niche at the intersection of healthcare and hospitality, with exposure to medical facilities and high value-added hotel services. This combination enables it to generate revenue tied to hard-to-replicate healthcare assets, while positioning itself on a differentiated service quality within the Swiss landscape.

Strengths
  • Defensive positioning backed by healthcare assets and care infrastructure
  • Hybrid healthcare-hospitality model offering clear differentiation and complementary revenue streams
  • Swiss base, a market renowned for the quality and stability of its medical standards
Weaknesses
  • High sensitivity to operating costs and regulatory constraints in the medical sector
  • Irregular stock market history, suggesting valuation may depend on specific catalysts and sustained operational execution
Momentum

Momentum appears decent but still moderate, with a more visible recent rebound after a period of underperformance over several years. The current trend seems better oriented, without signs of overheating, which points to a gradual recovery profile rather than a sharp acceleration. In the absence of notable recent news, the strategic focus remains on confirming a durable improvement in operational performance.

Similar stocks to AEVIS N

Anantys Community

Be the first to share your analysis on AEVIS N.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases